Created in 2008 (United States), Alnara Pharmaceuticals own 588 sister brands and 17477 competing brands. Alnara Pharmaceuticals is a brand of ELI LILLY AND COMPANY, listed on the stock exchange of New York. Alnara Pharmaceuticals is part of the Drug Manufacturers activity sector.

Alnara Pharmaceuticals is a brand of ELI LILLY AND COMPANY (LLY) Share price

Date created : 2008 Business sector Drug Manufacturers

Share price and profitability of the share ELI LILLY AND COMPANY (Alnara Pharmaceuticals)

Buy ELI LILLY AND COMPANY share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 745.69

Portfolio valuation
ELI LILLY AND COMPANY (Alnara Pharmaceuticals) over 5 years* USD 4,684.53

Stock market history ELI LILLY AND COMPANY (Alnara Pharmaceuticals)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
ELI LILLY AND COMPANY

POINT BIOPHARMA
POINT BIOPHARMA
DICE MOLECULES
DICE MOLECULES
DICE Therapeutics
DICE Therapeutics
Versanis
Versanis
ChemGen
ChemGen
Pharmaserve-Lilly
Pharmaserve-Lilly
See more brands of ELI LILLY AND COMPANY

Rival brands
Alnara Pharmaceuticals

Icosavax
Icosavax
OGX
OGX
MAUI MOISTURE
MAUI MOISTURE
POLYSPORIN
POLYSPORIN
LACTAID
LACTAID
ZARBEE'S
ZARBEE'S
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands > Pricing Power > 5 major sectors
Desirable brands > Pricing Power > 5 major sectors

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS